Pembrolizumab before surgery (neoadjuvant) then with radiotherapy after surgery (adjuvant) for newly diagnosed, resectable, locally advanced, squamous cell head and neck cancer [ID6477]
In development
Reference number: GID-TA11599
Expected publication date:
Documents
Documents created during the development process.
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators